Morgan Stanley

Alliance for Children's Mental Health Advisory Board

 

The Advisory Board of The Morgan Stanley Alliance for Children’s Mental Health brings together Morgan Stanley experts in medicine and philanthropy with prominent leaders in the mental health field. Together they work to deliver the strategic priorities of the Alliance and to guide it in its mission of supporting mental health in children, adolescents and young adults.

Bios
Joan Steinberg

Joan Steinberg

Global Head of Philanthropy, President, Morgan Stanley Foundation

 

Joan Steinberg is the Global Head of Philanthropy and President of the Morgan Stanley Foundation. After nine years in the nonprofit sector, Ms. Steinberg joined Morgan Stanley in 1997. She currently oversees Morgan Stanley’s global philanthropic programs, including strategic planning and execution, employee engagement, and corporate and Foundation grantmaking totaling more than $100 million annually. More than 90% of the Firm’s 60,000+ employees are active in these programs. Ms. Steinberg currently serves as member of the board of the Hispanic Federation, the SIFMA Foundation and the Friends of Elysian Charter School and as an Executive Committee member of the Children’s Advisory Council of New York Presbyterian Hospital.

Harold S. Koplewicz, MD

Harold S. Koplewicz, MD

Founding President and Medical Director of the Child Mind Institute

 

Harold S. Koplewicz, MD, is the founding president and medical director of the Child Mind Institute. One of the nation’s leading child and adolescent psychiatrists, he is known as an innovator in the field, a strong advocate for child mental health and a master clinician. Dr. Koplewicz has been repeatedly recognized in America’s Top Doctors, Best Doctors in America and New York Magazine‘s “Best Doctors in New York,” and was named one of WebMD’s 2014 Health Heroes for his advocacy on behalf of children with mental health and learning disorders. He is the past director of the Nathan Kline Institute for Psychiatric Research and the editor-in-chief of the Journal of Child and Adolescent Psychopharmacology. 

John MacPhee

John MacPhee

Executive Director/CEO of the Jed Foundation (JED)

 

John MacPhee brings 25 years of leadership experience to his role as CEO of The Jed Foundation, a nonprofit that protects emotional health and prevents suicide for our nation’s teens and young adults. JED partners with high schools and colleges to strengthen their mental health, substance misuse, and suicide prevention approaches, and equips emerging adults with the skills and knowledge to help themselves and each other. Passionate about supporting young adults, John advises the S. Jay Levy Fellowship for Future Leaders at City College, Trek Medics, Crisis Text Line, the Health Policy and Management Department at the Mailman School of Public Health, and HIV Hero. John is a recipient of The Allan Rosenfield Alumni Award for Excellence in the field of public health from Columbia University. He earned a BA and MPH from Columbia University, and an MBA from New York University.

Annelle Primm, MD

Annelle Primm, MD

Senior Medical Adviser of the Steve Fund

 

Dr. Annelle Primm is Senior Medical Director of the Steve Fund, an organization focused on the mental health of young people of color including college students. As convener of the All Healers Mental Health Alliance, she mobilizes collaborations to provide healing services for disaster-affected marginalized communities. Previously, Dr. Primm was Deputy Medical Director of the American Psychiatric Association from 2004-2015. Dr. Primm currently serves as an adjunct Associate Professor of Psychiatry at Johns Hopkins, New York University, and Howard University Schools of Medicine.

David Stark, MD

David Stark, MD

Chief Medical Officer, Head of HR Data & Analytics, Morgan Stanley

 

David Stark is a Managing Director of Morgan Stanley and serves as Chief Medical Officer and Head of HR Data & Analytics. He joined the firm in 2018 from Mount Sinai Health System, where he was the Medical Director of the Institute for Next Generation Healthcare and an Assistant Professor of Health System Design. Prior to that, David was a research fellow in the departments of medicine and bioengineering at Stanford University School of Medicine. David is a licensed physician, board certified in pediatric neurology and clinical informatics.

Jeremy Veenstra-VanderWeele, MD

Jeremy Veenstra-VanderWeele, MD

Director of Child & Adolescent Psychiatry at NewYork-Presbyterian Morgan Stanley Children’s Hospital and Columbia University Irving Medical Center

 

Jeremy Veenstra-VanderWeele, MD, is the Ruane Professor for the Implementation of Science for Child and Adolescent Mental Health at Columbia University Vagelos College of Physicians and Surgeons; Director of the Division of Child & Adolescent Psychiatry at NewYork-Presbyterian Morgan Stanley Children’s Hospital, New York State Psychiatric Institute (NYSPI), and Columbia University; and Acting Director of the Center for Autism and the Developing Brain, a collaborative program between NewYork-Presbyterian, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons. He is also Co-Director of both the National Institute of Mental Health T32 Postdoctoral Fellowship for Translational Research in Child Psychiatric Disorders and the Whitaker Scholar Program in Developmental Neuropsychiatry at the New York State Psychiatric Institute/Columbia University Irving Medical Center.

 

Dr. Veenstra-VanderWeele is a child and adolescent psychiatrist who uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism spectrum disorder and pediatric obsessive-compulsive disorder. Prior to joining the Department of Psychiatry at Columbia in 2014, Dr. Veenstra-VanderWeele was Director of the Division of Child and Adolescent Psychiatry at Vanderbilt University, where he was also an Associate Professor and Medical Director for the Treatment and Research Institute for Autism Spectrum Disorder.

©2020 Morgan Stanley & Co. LLC and Morgan Stanley Smith Barney LLC.  Members SIPC.   CRC 2865004 2/2020